Tomofumi Uto Selected Research

octaarginine

12/2019	Cross-Protective Abilities of Hyaluronic Acid Modified with Tetraglycine-l-octaarginine as a Mucosal Adjuvant against Infection with Heterologous Influenza Viruses.
1/2019	Biodegradable Hyaluronic Acid Modified with Tetraglycine-l-octaarginine as a Safe Adjuvant for Mucosal Vaccination.
1/2018	Effects of the Chemical Structures of Oligoarginines Conjugated to Biocompatible Polymers as a Mucosal Adjuvant on Antibody Induction in Nasal Cavities.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tomofumi Uto Research Topics

Disease

8	Infections 02/2022 - 05/2005
6	Inflammation (Inflammations) 01/2021 - 04/2016
5	Virus Diseases (Viral Diseases) 12/2019 - 08/2007
3	Communicable Diseases (Infectious Diseases) 05/2015 - 03/2007
2	Hypersensitivity (Allergy) 12/2020 - 01/2018
2	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2020 - 01/2017
2	Human Influenza (Influenza) 12/2019 - 01/2019
2	Anaphylaxis (Anaphylactic Shock) 01/2018 - 03/2017
2	Neoplasms (Cancer) 05/2015 - 08/2007
1	Dermatitis 01/2020
1	Asthma (Bronchial Asthma) 01/2018
1	Glomerulonephritis 04/2016
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 04/2016
1	Psoriasis (Pustulosis Palmaris et Plantaris) 04/2016

Drug/Important Bio-Agent (IBA)

6	AntigensIBA 01/2018 - 05/2005
4	chenodeoxycholate sulfate conjugate (CDCS)IBA 01/2021 - 01/2016
4	Immunoglobulin A (IgA)IBA 12/2019 - 01/2016
4	VaccinesIBA 05/2015 - 05/2005
3	octaarginineIBA 12/2019 - 01/2018
2	Pattern Recognition ReceptorsIBA 01/2020 - 01/2017
2	Viral AntigensIBA 12/2019 - 01/2019
2	Immunoglobulin G (IgG)IBA 12/2019 - 01/2019
2	LigandsIBA 01/2017 - 04/2016
2	poly(gamma-glutamic acid) (gamma-PGA)IBA 01/2008 - 03/2007
1	PolymersIBA 02/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2021
1	AllergensIBA 12/2020
1	Glycoproteins (Glycoprotein)IBA 01/2020
1	C-Type Lectins (C-Type Lectin)IBA 01/2020
1	CarbohydratesIBA 01/2020
1	Polysaccharides (Glycans)IBA 12/2019
1	glycyl-glycyl-glycyl-glycineIBA 12/2019
1	Hyaluronic Acid (Hyaluronan)IBA 12/2019
1	interleukin-22 receptor (IL-22R)IBA 01/2018
1	Carrier Proteins (Binding Protein)IBA 01/2018
1	InterleukinsIBA 01/2018
1	Interleukin-22 (IL-22)IBA 01/2018
1	poly(N-vinylacetamide)IBA 01/2018
1	acrylic acid (acrylate)IBA 01/2018
1	Immunoglobulin E (IgE)IBA 03/2017
1	CytokinesIBA 01/2017
1	Toll-Like Receptors (Toll-Like Receptor)IBA 04/2016
1	Antiviral Agents (Antivirals)IBA 04/2016
1	AntibodiesIBA 04/2016
1	Interferon Type IIBA 04/2016
1	Nucleic AcidsIBA 04/2016
1	nasIBA 04/2016
1	Proteins (Proteins, Gene)FDA Link 01/2008
1	Vaccine AdjuvantsIBA 03/2007

Therapy/Procedure

1	Therapeutics 03/2007